Original Contributions |
From the Centro de Investigaciones Cardiovasculares, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, Calle 60 y 120 S/N, 1900 La Plata, Argentina.
Correspondence to Dr Horacio E. Cingolani, Centro de Investigaciones Cardiovasculares, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, Calle 60 y 120, 900 La Plata, Argentina. E-mail cicme{at}isis.unlp.edu.ar
| Abstract |
|---|
|
|
|---|
92% Lmax (Li). During the "stretch
protocol," muscles were quickly stretched to Lmax for 10
minutes and then released to Li; pHi
significantly increased during stretch and came back to the previous
value when the muscle was released to Li. The increase in
pHi was eliminated by (1) specific inhibition of the NHE
(EIPA, 5 µmol/L), (2) AT1-receptor blockade
(losartan, 10 µmol/L), (3) inhibition of protein kinase
C (PKC) (chelerythrine, 5 µmol/L), (4) blockade of endothelin
(ET) receptors with a nonselective (PD 142,893, 50 nmol/L) or a
selective ETA antagonist (BQ-123, 300 nmol/L).
The increase in pHi by exogenous Ang II (500 nmol/L) was
also reduced by both ET-receptor antagonists. Our results
indicate that after myocardial stretch, pHi increases
because of stimulation of NHE activity. This involves an
autocrine-paracrine mechanism in which protein kinase C, Ang II, and ET
play crucial roles.
Key Words: stretch, myocardial pH, intracellular Na+/H+ exchange angiotensin endothelin
| Introduction |
|---|
|
|
|---|
Experiments in feline papillary muscles were designed to monitor myocardial pHi before and after stretch. Our results indicate that after myocardial stretch, the increase in myocardial pHi is an early intracellular signal involving an autocrine-paracrine system.
| Materials and Methods |
|---|
|
|
|---|
Measurements of pHi in the isolated muscles were made after loading the muscles with the acetoxymethyl ester form of the pH-sensitive dye 2',7'-bis(2-carboxyethyl)-5,6-carboxyfluorescein (BCECF-AM, Molecular Probes), as previously described.18 Washout of the extracellular space with dye-free solution was continued until stable fluorescence signals were obtained (usually within 90 minutes). BCECF fluorescence was excited at 450 and 495 nm, and the fluorescence emission monitored after passage through a 535±5 nm filter. To limit photobleaching, a neutral-density filter (1% transmittance) was placed in the excitation light path, and a manual shutter was used to select sampling intervals (for 3 seconds every 15 seconds) during the protocol. When the experiments began, fluorescence at H+-insensitive wavelength was usually 5x greater than the original autofluorescence. At the end of each experiment, fluorescence emission was calibrated by the high K+nigericin method.19 The calibration solution contained (in mmol/L): KCl 140.0, MgCl2 1.0, CaCl2 1.0, HEPES 5.0, nigericin 0.01, sodium cyanide 4.0, and 2,3-butanedionemonoxime 20.0.18 Buffer pH was adjusted with KOH to 4 different values ranging from 7.5 to 6.5. This calibration gave a linear relation (r=0.95±0.03, n=32) between buffer pH values and the fluorescence ratio (F495/F450). The fluorescence ratio was calculated as follows: ratio=fluorescence495-autofluorescence495/fluorescence450-autofluorescence450. When muscles are stretched, their volume that is visible to the photomultiplier is reduced, and consequently, the autofluorescence and pH-related signals may decrease. We found that in unloaded muscles the autofluoresece at 450 and 495 nm changed by 1.45±1.58% and 0.93±0.98%, respectively, which was not significantly different from zero (P>0.05, t test). Moreover, since BCECF is a ratio indicator, the importance of the change is greatly reduced because both recorded signals are almost equally affected, and therefore the change is largely eliminated by the use of ratios.
The experimental protocol designed for our study was as follows: after
mounting, the values of slack length (Ls) and
width of each muscle were determined with a reticle in the eyepiece of
a SZ30 Olympus Zoom stereomicroscope set at a total magnification of
x30. Because the geometry of each long, slender papillary muscle
approximates a cylinder, muscle cross-sectional area was calculated
with the use of width/2 as radius value. Each muscle was progressively
stretched to reach the length at which the force developed during the
twitch was maximal (Lmax). After
Lmax was determined, muscle length was reduced to
92% of Lmax, and this length was maintained
for 2 hours. Afterward, the muscle was stretched by manual adjustment
of the micrometer to the previously determined value of
Lmax, and then released to the previous length.
In the majority of the experiments, the stretch lasted 10 minutes;
however, in a group of 4 muscles, the stretch was maintained for a
longer period to assure pHi had reached a steady
value. Stretching of the muscles caused resting and developed tension
to increase by 128±40% and 167±3%, respectively.
pHi was measured before, during, and after the stretch protocol under control conditions and after treatment with 1 of the following compounds: 5 µmol/L 5-(N-ethyl-N-isopropyl)amiloride (EIPA), 5 µmol/L chelerythrine chloride, 10 µmol/L losartan, 50 nmol/L PD 142,893, and 300 nmol/L BQ-123. All compounds were purchased from Biochemical Research International, with the exception of losartan, which was a kind gift from Dupont Merck (West Point, Pa). The pHi response to exogenous Ang II and ET-1 (Sigma-Aldrich) was assessed in the absence or presence of AT1- or ET-receptor antagonists.
Statistics
Data were expressed as mean±SEM, and analyzed by the
Student t test, repeated-measures ANOVA, or 1-way ANOVA, as
appropriate. Values of P<0.05 were considered
significant.
| Results |
|---|
|
|
|---|
|
|
Because the only pHi regulatory mechanism in the
absence of bicarbonate is the NHE, an activation of this exchanger
probably mediates the decrease in intracellular proton concentration.
Similar experiments to those shown in Figure 1
were repeated in the
presence of 5 µmol/L EIPA (Figure 3
). Under this condition, we were unable
to detect any significant change in pHi with
stretch, which strongly suggests that the activation of NHE was
underlying the increase of pHi, as illustrated in
Figure 1
. Although the possibility of nonspecific actions of EIPA on
other processes cannot be completely excluded,20
this amiloride analogue seems to be specific for NHE at the dosage used
here.14 21 Previous results from our laboratory,
which used the same experimental preparation (ie, isolated cat
papillary muscle), showed that 5 µmol/L EIPA inhibited by
70% the recovery from hypercapnic acidosis.22
|
The activation of NHE may be the result of PKC stimulation induced
either by the release of Ang II and/or ET, by the increase in tensile
stress, or through other mechanisms. Figure 4
shows that in the presence of a PKC
inhibitor, such as chelerythrine, the increase in
pHi mediated by stretch was eliminated, which
suggests the involvement of a PKC-dependent pathway in stretch-induced
activation of NHE. Both a tendency of baseline
pHi to decrease and a small, statistically
insignificant decrease in pHi after stretch were
observed in the presence of chelerythrine. The decline in baseline
pHi probably results from either a decrease in
basal phosphorylation(s) or from nonspecific
inhibitory actions of chelerythrine, as recently reported
in cardiac muscle.23 The small decrease in
pHi after stretch observed in the presence of
chelerythrine may be a consequence of the known stretch-induced
increase in intracellular calcium
concentration.24 25 An increase in intracellular
calcium can displace protons from binding sites and decrease
pHi.26
|
Figure 5
shows the increase in
pHi after stretch was also eliminated by blockade
of AT1 receptors with 10 µmol/L
losartan. These results suggest that the increase in
pHi after myocardial stretch came from the
release of Ang II, which in turn increased PKC activity leading to NHE
hyperactivity. Similarly to chelerythrine, losartan induced a
slight (not statistically significant) decrease of baseline
pHi. We speculate that both pharmacological
interventions decrease NHE activity probably decreasing basal
phosphorylation. Implicit in our speculation is the
assumption of some basal production of Ang II and activation of
PKC.
|
However, we thought that Ang II could promote the synthesis and release
of ET from cardiomyocytes, endothelial
cells, and even from fibroblasts.15 27 28 29 ET has
been shown to increase PKC activity,16 to
activate the NHE,12 14 16 17 and to act
as a growth factor increasing c-fos expression as well as
DNA and protein synthesis.30 For these reasons,
experiments were performed in which the papillary muscles were
stretched after the blockade of ET receptors with a nonselective (PD
142,893) or a selective ETA
antagonist (BQ-123). Figure 6
shows both antagonists of ET receptors suppressed the
increase in pHi induced by stretch.
|
A reasonable interpretation of these data is that stretching the papillary muscle induces the release of Ang II from myocardial cells, which in turn causes synthesis and/or release of ET. This is in agreement with previous results in neonatal cardiomyocytes showing that Ang II induces (within 30 minutes) a PKC-dependent increase in prepro ET-1 mRNA levels and the release of ET-1.15
The well-known effect of Ang II to increase myocardial
pHi,8 10 11 12 13 14 previously
suggested to be the main mechanism for its positive inotropic
effect,10 may be the result of an
autocrine-paracrine system mediated through ET receptors. If this
interpretation is correct, the effect of Ang II on
pHi should be reduced by ET receptor blockade.
This possibility was explored in the experiments shown in Figure 7
. The effect of ET receptors blockade on
the pHi response to Ang II was analyzed
in these experiments. Figure 7A
shows the increase in myocardial
pHi that resulted after the application of 500
nmol/L Ang II. Pilot experiments have shown that the increase in
pHi induced by exogenous Ang II was related to
its concentration; for example, the rise in pHi
was maximal at 1 µmol/L, and 30% or 96% of the maximal effect
was obtained with 10 and 500 nmol/L, respectively. Figure 7B
and 7C
shows the suppression of Ang II effect on myocardial
pHi by the nonselective endothelin receptor
antagonist PD 142,893, as well as by the selective
ETA blocker, BQ-123. However, a potential
explanation for our findings is that PD 142,893 and BQ-123 were
nonspecifically inhibiting the binding of Ang II to the
AT1 receptors. This possibility seems improbable
because the positive inotropic effect of Ang II was preserved in the
presence of both ET receptor antagonists. Developed tension
increased by 120±49% (n=4) after Ang II in the presence of PD 142,893
and by 143±25% (n=4) in the presence of BQ-123; whereas, under
control conditions the same concentration of Ang II increased
myocardial contractility in a similar extent
(144±36%, n=5). These results rule out the possibility of nonspecific
blockade of AT1 receptors by ET
antagonists. A previous report has suggested a causal link
between the increase in pHi and in
contractility after Ang II.10
However, our results demonstrate that intracellular alkalinization does
not play a significant role in the positive inotropic effect of Ang II
in myocardial tissue. The dissociation between the positive inotropic
effect of Ang II and the increase in pHi has been
previously reported from our laboratory.31
|
The pHi response to exogenous ET-1 in our
preparation of intact papillary muscle superfused with HEPES-buffered
medium is shown in Figure 8
. ET-1 induced
a concentration-dependent increase in pHi with a
maximum within the nanomolar range. ET-1 at 10 pmol/L caused an
elevation of pHi similar to that seen during
stretch (0.11±0.04). ET-1 concentrations around this order of
magnitude have been found in cultures of
cardiomyocytes3 32 and of
endothelial cells.27
|
The pHi response to ET-1 was not changed by the blockade of AT1-subtype of receptors. When 10 pmol/L ET-1 was assayed in the presence of losartan, about the same increase in pHi was detected (0.12±0.02, n=4). These results indicate that the activation of NHE by ET is a consequence of the direct effect of the peptide through ET receptors and argue against the possibility that both Ang II and ET may be required for activation of NHE.
| Discussion |
|---|
|
|
|---|
The potential importance of the increase in myocardial pHi after the increase in muscle length is not a previously recognized effect of stretch. However, we should be cautious to extrapolate these findings to the more physiological conditions in which the bicarbonate-dependent mechanisms are operative. An acid-loading bicarbonate-dependent mechanism, the sodium independent Cl-/HCO3- exchanger, is also activated by Ang II.35 Therefore, an argument can be made that if the alkalinizing effect of stretch can be detected only in the absence of bicarbonate, the finding is merely a biochemical curiosity. Even if this were true (ie, no significant changes in pHi after stretch when the bicarbonate-dependent mechanisms are operative), our findings allow us to arrive at the following conclusions: (1) Mechanical stretch causes the release of Ang II from feline, adult papillary muscles. In agreement with a recent report,6 these results provide direct evidence of the autocrine-paracrine mechanism in the adult heart. (2) An activation of the NHE is detected after mechanical stretch. This activation is eliminated not only by AT1-receptor blockade but also by 2 different ET antagonists. (3) Under our experimental conditions, the increase in myocardial pHi detected after Ang II was because of the autocrine-paracrine effect of ET. Both the selective ETA and the nonselective ET-receptor antagonists suppressed the increase in pHi mediated by Ang II. (4) Whether or not myocardial pHi changes under physiological conditions (ie, in HCO3-containing solutions), an increase in [Na+]i caused by the hyperactivity of NHE in the presence of Ang II is expected. The increase in [Na+]i may still be present even if the effect of the increased activity of NHE on pHi were eliminated by the enhanced activity of the anion exchanger.35 This [Na+]i increase will lead to a secondary increase in [Ca2+]i, through the Na+/Ca2+ exchanger and may contribute to the positive inotropic effect of Ang II. Although we cannot completely rule out the contribution of increases in pHi to the increase in contractility induced by Ang II, our results indicate that, at least in feline myocardium, intracellular alkalinization does not play a significant role in its positive inotropic effect.
Our experiments were performed in a multicellular preparation. This preparation, although more representative of mechanisms operating in the whole heart, does not enable dissection of the particular cell type(s) involved in the chain of events triggered by stretch. These factors are particularly important because papillary muscles contain endothelial endocardial cells and fibroblasts in addition to myocytes. A recent suggestion is that fibroblasts are the source of ET released by Ang II and play a critical role in the hypertrophy of cardiomyocytes in culture.29
Nevertheless, we were able to demonstrate in an adult multicellular preparation that stretch of the muscle activates NHE through a mechanism involving PKC activation and an autocrine-paracrine system in which Ang II and ET are steps in the chain of events. The implications of this phenomenon on protein synthesis and myofilament responsiveness after stretch deserves further investigation. A recent report shows that ETA-receptor antagonists diminished the hypertensive response to Ang II,36 and hints at the possibility that some of the effects thought to be caused by Ang II are in fact mediated by ET.
| Acknowledgments |
|---|
Received April 6, 1998; accepted July 16, 1998.
| References |
|---|
|
|
|---|
2. Sadoshima J, Izumo S. Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism. EMBO J. 1993;12:16811692.[Medline] [Order article via Infotrieve]
3. Sadoshima J, Xu Y, Sleiter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 1993;75:977984.[Medline] [Order article via Infotrieve]
4.
Kojima M, Shiojima I, Yamazaki T, Komuro I, Yunzeng Z,
Ying W, Mizuno T, Uceki K, Tobe K, Kadowaki T, Nagai R, Yazaki Y.
Angiotensin II receptor antagonist TCV-116
induces regression of hypertensive left ventricular
hypertrophy in vivo and inhibits the intracellular
signaling pathway of stretch mediated cardiomyocyte
hypertrophy in vitro. Circulation. 1994;89:22042211.
5.
Yamazaki T, Komuro I, Kudoh S, Zou Y, Shiojima I,
Mizuno T, Takano H, Hiroi Y, Ueki K, Tobe K, Kadowaki T, Nagai R,
Yazaki Y. Angiotensin II partly mediates mechanical
stress-induced cardiac hypertrophy. Circ Res. 1995;77:258265.
6.
Paul K, Ball NA, Dorn GW II, Walsh RA. Left
ventricular stretch stimulates angiotensin
II-mediated phosphatidylinositol hydrolysis and protein kinase C
isoform translocation in adult guinea pig hearts. Circ
Res. 1997;81:643650.
7.
Wakabayashi S, Shigekawa M, Pouyssegur J. Molecular
physiology of vertebrate
Na+/H+ exchangers.
Physiol Rev. 1997;77:5174.
8.
Takabashi E, Abe J, Berk BC. Angiotensin
II stimulates p90rsk in vascular smooth muscle
cells: a potential Na+/H+
exchanger kinase. Circ Res. 1997;81:268273.
9. Takewaki S, Kuro-o M, Hiroi Y, Yamazaki T, Noguchi T, Miyagishi A, Nakahara K, Aikawa M, Manabe I, Yazaki Y, Nagai R. Activation of Na+/H+ antiporter (NHE-1) gene expression during growth hypertrophy and proliferation of rabbit cardiovascular system. J Mol Cell Cardiol. 1995;27:729742.[Medline] [Order article via Infotrieve]
10.
Ikenouchi L, Barry WH, Bridge JHB, Weinberg EO, Apstein
CS, Lorell H. Effects of angiotensin II on intracellular
Ca2+ and pH in isolated beating rabbit hearts and
myocytes loaded with the indicator indo-1. J Physiol
(Lond). 1994;480:203215.
11. Matsui H, Barry W, Livsey C, Spitzer KW. Angiotensin II stimulates sodium-hydrogen exchange in adult rabbit ventricular myocytes. Cardiovasc Res. 1995;29:215221.[Medline] [Order article via Infotrieve]
12. Ito N, Kagaya Y, Weinberg EO, Barry WH, Lorell BH. Endothelin and angiotensin II stimulation of Na+/H+ exchange is impaired in cardiac hypertrophy. J Clin Invest. 1997;99:125135.[Medline] [Order article via Infotrieve]
13.
Grace AA, Metacalfe JC, Weissberg PL, Bethell HWL,
Vanderberg JI. Angiotensin II stimulates sodium-dependent
proton extrusion in perfused ferret heart. Am J
Physiol. 1996;270:C1687C1694.
14. Talukder MAH, Endoh M. Pharmacological differentiation of synergistic contribution of L-type Ca2+ channels and Na+/H+ exchange to the positive inotropic effect of phenylephrine, endothelin-3 and angiotensin II in rabbit ventricular myocardium. Naunyn Schmiedebergs Arch Pharmacol. 1997;355:8796.[Medline] [Order article via Infotrieve]
15. Ito H, Hirata Y, Adachi S, Tanaka M, Tsujino M, Kioke A, Nogami A, Marumo F, Hiroe M. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest. 1993;92:398403.
16.
Krämer BK, Smith WT, Kelly RA. Endothelin and
increased contractility in adult rat
ventricular myocytes: role of intracellular alkalosis
induced by activation of the protein kinase C-dependent
Na+/H+ exchanger.
Circ Res. 1991;68:269279.
17.
Kohmoto O, Ikenouchi H, Hirata Y, Momomura SI, Serizawa
T, Barry WH. Variable effects of endothelin-1 on
[Ca2+]i transients,
pHi, and contraction in ventricular
myocytes. Am J Physiol. 1993;265:H793H800.
18.
Camilión de Hurtado MC, Alvarez BV, Pérez
NG, Cingolani HE. Role of an electrogenic
Na+-HCO3-
cotransport in determining myocardial pHi after
an increase in heart rate. Circ Res. 1996;79:698704.
19. Thomas JA, Buchsbaum RN, Zimniak A, Racker E. Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ. Biochemistry. 1979;18:22102218.[Medline] [Order article via Infotrieve]
20.
Pierce GN, Cole WC, Liu K, Massaeli H, Maddaford
TG, Chen YJ, McPherson CD, Jain S, Sontag D. Modulation of cardiac
performance by amiloride and several selected derivatives of
amiloride. J Pharmacol Exp Ther. 1993;265:12801291.
21. Kleyman TR, Cragoe EJ Jr. Amiloride and its analogs as tools in the study of ion transport. J Membr Biol. 1988;105:121.[Medline] [Order article via Infotrieve]
22. Pérez NG, Mattiazzi A, Camilión de Hurtado MC, Cingolani HE. Myocardial contractility recovery during hypercapnic acidosis: its dissociation from recovery in pHi by ryanodine. Can J Cardiol. 1995;11:553560.[Medline] [Order article via Infotrieve]
23.
Talukder MAH, Endoh M. Differential effects of protein
kinase C activators and inhibitors on
-and ß-adrenoceptor-mediated positive inotropic effect in
isolated rabbit papillary muscle. J Cardiovasc Pharmacol
Ther. 1997;2:159170.
24.
Allen DG, Kurihara S. The effects of muscle length on
intracellular calcium transients in mammalian cardiac muscle.
J Physiol (Lond). 1982;327:7994.
25.
Hongo K, White E, Orchard CH. Effect of stretch on
contraction and the Ca2+ transient in ferret
ventricular muscles during hypoxia and acidosis.
Am J Physiol. 1995;269:C690C697.
26. Vaughan-Jones RD, Lederer WJ, Eisner DA. Ca2+ ions can affect intracellular pH in mammalian cardiac muscle. Nature. 1989;301:522524.
27.
Emori T, Hirata Y, Ohta K, Kanno K, Eguchi S, Imai T,
Shichiri M, Marumo F. Cellular mechanism of endothelin-1 release by
angiotensin and vasopressin. Hypertension. 1991;18:165170.
28.
Mebazaa A, Mayoux E, Maeda K, Martin LD, Lakatta EG,
Robotham JL, Shah AM. Paracrine effects of endocardial
endothelial cells on myocytes contraction mediated via
endothelin. Am J Physiol. 1993;265:H1841H1846.
29.
Harada M, Itoh H, Nakagawa O, Ogawa Y, Miyamoto Y,
Kuwahara K, Ogawa E, Igaki T, Yamashita J, Masuda I, Yoshimasa T,
Tanaka I, Saito Y, Nakao K. Significance of ventricular
myocytes and nonmyocytes interaction during cardiocyte
hypertrophy: evidence for endothelin-1 as a paracrine
hypertrophic factor from cardiac nonmyocytes.
Circulation. 1997;96:37373744.
30.
Ito H, Hirata Y, Hiroe M, Tsujino M, Adachi S, Takamoto
T, Nitta M, Taniguchi K, Marumo F. Endothelin-1 induces
hypertrophy with enhanced expression of muscle-specific
genes in cultured neonatal rat cardiomyocytes. Circ
Res. 1991;69:209215.
31.
Mattiazzi A, Pérez NG, Vila-Petroff MG, Alvarez
B, Camilión de Hurtado MC, Cingolani HE. Dissociation between
positive inotropic and alkalinizing effects of angiotensin
II in feline myocardium. Am J Physiol. 1997;272:H1131H1136.
32.
Yamazaki T, Komuro I, Kudoh S, Zou Y, Shiojima I, Hiroi
Y, Mizuno T, Maemura K, Kurihara H, Aikawa R, Takano H, Yazaki Y.
Endothelin-1 is involved in mechanical stress-induced
cardiomyocyte hypertrophy. J Biol
Chem. 1995;271:32213228.
33.
Schlüter K-D, Millar BC, McDermott BJ, Piper HM.
Regulation of protein synthesis and degradation in adult
ventricular cardiomyocytes. Am J
Physiol. 1995;269:C1347C1355.
34.
Yamazaki T, Komuro I, Kudoh S, Zou Y, Nagai R, Aikawa
R, Uozumi H, Yazaki Y. Role of ion channels and exchangers in
mechanical stretch-induced cardiomyocyte
hypertrophy. Circ Res. 1998;82:430437.
35.
Camilión de Hurtado MC, Alvarez BV, Pérez
NG, Ennis IL, Cingolani HE. Angiotensin II
activates Na+-independent
Cl-/HCO3- exchange in
ventricular myocardium. Circ Res. 1998;82:473481.
36.
Rajagopalan S, Laursen JB, Borthayre A, Kurz S, Keiser
J, Hallen S, Giaid A, Harrison DG. Role for endothelin-1 in
angiotensin II-mediated hypertension.
Hypertension. 1997;30:2934.
This article has been cited by other articles:
![]() |
D. von Lewinski, J. Kockskamper, D. Zhu, H. Post, A. Elgner, and B. Pieske Reduced Stretch-Induced Force Response in Failing Human Myocardium Caused by Impaired Na+-Contraction Coupling Circ Heart Fail, January 1, 2009; 2(1): 47 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kockskamper, M. Khafaga, M. Grimm, A. Elgner, S. Walther, A. Kockskamper, D. von Lewinski, H. Post, M. Grossmann, H. Dorge, et al. Angiotensin II and myosin light-chain phosphorylation contribute to the stretch-induced slow force response in human atrial myocardium Cardiovasc Res, September 1, 2008; 79(4): 642 - 651. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Luers, F. Fialka, A. Elgner, D. Zhu, J. Kockskamper, D. von Lewinski, and B. Pieske Stretch-dependent modulation of [Na+]i, [Ca2+]i, and pHi in rabbit myocardium-a mechanism for the slow force response Cardiovasc Res, December 1, 2005; 68(3): 454 - 463. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Baartscheer, C. A. Schumacher, M. M.G.J. van Borren, C. N.W. Belterman, R. Coronel, T. Opthof, and J. W.T. Fiolet Chronic inhibition of Na+/H+-exchanger attenuates cardiac hypertrophy and prevents cellular remodeling in heart failure Cardiovasc Res, January 1, 2005; 65(1): 83 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Fransen, R. R Lamberts, J. Hendrickx, and G. W De Keulenaer Endocardial endothelium modulates subendocardial pHi of rabbit papillary muscles: role of transendothelial HCO3- transport Cardiovasc Res, September 1, 2004; 63(4): 700 - 708. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. von Lewinski, B. Stumme, F. Fialka, C. Luers, and B. Pieske Functional Relevance of the Stretch-Dependent Slow Force Response in Failing Human Myocardium Circ. Res., May 28, 2004; 94(10): 1392 - 1398. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chen, C. X. Chen, X. T. Gan, N. Beier, W. Scholz, and M. Karmazyn Inhibition and reversal of myocardial infarction-induced hypertrophy and heart failure by NHE-1 inhibition Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H381 - H387. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G Perez, M. C Villa-Abrille, E. A Aiello, R. A Dulce, H. E Cingolani, and M. C Camilion de Hurtado A low dose of angiotensin II increases inotropism through activation of reverse Na+/Ca2+ exchange by endothelin release Cardiovasc Res, December 1, 2003; 60(3): 589 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Cingolani, G. E. Chiappe, I. L. Ennis, P. G. Morgan, B. V. Alvarez, J. R. Casey, R. A. Dulce, N. G. Perez, and M. C. Camilion de Hurtado Influence of Na+-Independent Cl--HCO3- Exchange on the Slow Force Response to Myocardial Stretch Circ. Res., November 28, 2003; 93(11): 1082 - 1088. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Pieske and S. R Houser [Na+]i handling in the failing human heart Cardiovasc Res, March 15, 2003; 57(4): 874 - 886. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E Cingolani, N. G Perez, B. Pieske, D. von Lewinski, and M. C Camilion de Hurtado Stretch-elicited Na+/H+ exchanger activation: the autocrine/paracrine loop and its mechanical counterpart Cardiovasc Res, March 15, 2003; 57(4): 953 - 960. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I Bak and J. S Ingwall Contribution of Na+/H+ exchange to Na+ overload in the ischemic hypertrophied hyperthyroid rat heart Cardiovasc Res, March 15, 2003; 57(4): 1004 - 1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Baartscheer, C.A Schumacher, M.M.G.J van Borren, C.N.W Belterman, R Coronel, and J.W.T Fiolet Increased Na+/H+-exchange activity is the cause of increased [Na+]i and underlies disturbed calcium handling in the rabbit pressure and volume overload heart failure model Cardiovasc Res, March 15, 2003; 57(4): 1015 - 1024. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. von Lewinski, B. Stumme, L. S Maier, C. Luers, D. M Bers, and B. Pieske Stretch-dependent slow force response in isolated rabbit myocardium is Na+ dependent Cardiovasc Res, March 15, 2003; 57(4): 1052 - 1061. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Lamberts, M. H. P. van Rijen, P. Sipkema, P. Fransen, S. U. Sys, and N. Westerhof Coronary perfusion and muscle lengthening increase cardiac contraction: different stretch-triggered mechanisms Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1515 - H1522. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Loennechen, U. Wisloff, G. Falck, and O. Ellingsen Effects of Cariporide and Losartan on Hypertrophy, Calcium Transients, Contractility, and Gene Expression in Congestive Heart Failure Circulation, March 19, 2002; 105(11): 1380 - 1386. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Camilion de Hurtado, E. L. Portiansky, N. G. Perez, O. R. Rebolledo, and H. E. Cingolani Regression of cardiomyocyte hypertrophy in SHR following chronic inhibition of the Na+/H+ exchanger Cardiovasc Res, March 1, 2002; 53(4): 862 - 868. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. L. Janssen, G. Hasenfuss, O. Zeitz, S. E. Lehnart, J. Prestle, D. Darmer, J. Holtz, and H. Schumann Load-dependent induction of apoptosis in multicellular myocardial preparations Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H349 - H356. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Cingolani, N. G. Perez, and M. C. Camilion de Hurtado An Autocrine/Paracrine Mechanism Triggered by Myocardial Stretch Induces Changes in Contractility Physiology, April 1, 2001; 16(2): 88 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Perez, M. C. C. de Hurtado, and H. E. Cingolani Reverse Mode of the Na+-Ca2+ Exchange After Myocardial Stretch : Underlying Mechanism of the Slow Force Response Circ. Res., March 2, 2001; 88(4): 376 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kusumoto, J. V. Haist, and M. Karmazyn Na+/H+ exchange inhibition reduces hypertrophy and heart failure after myocardial infarction in rats Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H738 - H745. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ruwhof and A. van der Laarse Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways Cardiovasc Res, July 1, 2000; 47(1): 23 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Parenti, X.-L. Cui, U. Hopfer, M. Ziche, and J. G. Douglas Activation of MAPKs in Proximal Tubule Cells From Spontaneously Hypertensive and Control Wistar-Kyoto Rats Hypertension, May 1, 2000; 35(5): 1160 - 1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K Borg, E. C Goldsmith, R. Price, W. Carver, L. Terracio, and A. M Samarel Specialization at the Z line of cardiac myocytes Cardiovasc Res, May 1, 2000; 46(2): 277 - 285. [Full Text] [PDF] |
||||
![]() |
M. C. C. de Hurtado, B. V. Alvarez, I. L. Ennis, and H. E. Cingolani Stimulation of Myocardial Na+-Independent Cl--HCO3- Exchanger by Angiotensin II Is Mediated by Endogenous Endothelin Circ. Res., March 31, 2000; 86(6): 622 - 627. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yoshida and M. Karmazyn Na+/H+ exchange inhibition attenuates hypertrophy and heart failure in 1-wk postinfarction rat myocardium Am J Physiol Heart Circ Physiol, January 1, 2000; 278(1): H300 - H304. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Cingolani Na+/H+ exchange hyperactivity and myocardial hypertrophy: Are they linked phenomena? Cardiovasc Res, December 1, 1999; 44(3): 462 - 467. [Full Text] [PDF] |
||||
![]() |
M. Karmazyn, X. T. Gan, R. A Humphreys, H. Yoshida, and K. Kusumoto The Myocardial Na+-H+ Exchange : Structure, Regulation, and Its Role in Heart Disease Circ. Res., October 29, 1999; 85(9): 777 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Kentish A Role for the Sarcolemmal Na+/H+ Exchanger in the Slow Force Response to Myocardial Stretch Circ. Res., October 15, 1999; 85(8): 658 - 660. [Full Text] [PDF] |
||||
![]() |
B. V. Alvarez, N. G. Perez, I. L. Ennis, M. C. Camilion de Hurtado, and H. E. Cingolani Mechanisms Underlying the Increase in Force and Ca2+ Transient That Follow Stretch of Cardiac Muscle : A Possible Explanation of the Anrep Effect Circ. Res., October 15, 1999; 85(8): 716 - 722. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Dostal and K. M. Baker Angiotensin and Endothelin : Messengers That Couple Ventricular Stretch to the Na+/H+ Exchanger and Cardiac Hypertrophy Circ. Res., October 19, 1998; 83(8): 870 - 873. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |